Cost-effectiveness of the once-daily efavirenz/ emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/ tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US

ClinicoEconomics and Outcomes Research

Targeted Therapies for Metastatic Colorectal Cancer: A Systematic Review of Cost Effectiveness

ASCO Gastrointestinal Cancers Symposium

The Cost-effectiveness of Improving Cancer Screening Compliance

ASCO Annual Meeting
Cancer, Cost Effectiveness Analysis, Economic Models, Oncology, Quality of Care

Budget Impact Analysis of Increasing LMWH/FXI Utilization

ISPOR Annual International Meeting
Budget Impact Model, Cardiology, Cost Effectiveness Analysis, Economic Models, Thromboembolism

Cost Effectiveness of Atazanavir-ritonavir Versus Lopinavir-ritonavir in Treatment-naive Human Immunodeficiency Virus-infected Patients in the United States

Journal of Medical Economics

Cost-effectiveness of 21-gene Assay in Node-positive, Early-stage Breast Cancer

The American Journal of Managed Care
Breast Cancer, Cancer, Cost Effectiveness Analysis, Economic Models, Oncology

Cost Effectiveness of Donepezil 23 mg in the Treatment of Moderate to Severe Alzheimer’s Disease from a US Payor Perspective

Alzheimer's Association International Conference
Alzheimer's Disease, Cost Effectiveness Analysis, Economic Models, Neurology

Bias Associated with Failing to Incorporate Dependence on Event History in Markov Models

Medical Decision Making
Cost Effectiveness Analysis, Economic Models, Modeling Methods

Cost effectiveness of atazanavir-ritonavir vs. lopinavir-ritonavir in HIV-infected patients initiating first-line antiretroviral therapy

International Congress on Drug Therapy in HIV Infection